Impact of pathological characteristics on local relapse after breast-conserving therapy: A subgroup analysis of the EORTC boost versus no boost trial

Journal of Clinical Oncology

Volumn 27, Issue 30, 2009, Pages 4939-4947

  Jones, Heather A ^a   Antonini, Ninja ^a   Hart, Augustinus A M ^a   Peterse, Johannes L ^a   Horiot, Jean Claude ^a   Collin, Françoise ^a   Poortmans, Philip M ^a   Oei, S Bing ^a   Collette, Laurence ^a   Struikmans, Henk ^a   Van Den Bogaert, Walter F ^a   Fourquet, Alain ^a   Jager, Jos J ^a   Schinagl, Dominic A X ^a   Wárlám Rodenhuis, Carla C ^a   Bartelink, Harry ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE;

ADULT; AGE FACTORS; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 74549138808     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.21.5764     Document Type: Article

References (50)

1. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow- up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002
2. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456-1461, 1995
3. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
4. Whelan TJ, Lada BM, Laukkanen E, et al: Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Cancer Prev Control 1:228-240, 1997
5. van Dongen JA, Voogd AC, Fentiman IS, et al: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organisation for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92:1143-1150, 2000
6. Arriagada R, Le MG, Rochard F, et al: Conservative treatment versus mastectomy in early breast cancer: Patterns of failure with 15 years of follow-up data: Institute Gustave-Roussy Breast Cancer Group. J Clin Oncol 14:1558-1564, 1996
7. Touboul E, Buffat L, Belkacemi Y, et al: Local recurrences and distant metastases after breastconserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43:25-38, 1999
8. Jacobson JA, Danforth DN, Cowan KH, et al: Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332:907-911, 1995
9. Haffty BG, Reiss M, Beinfield M, et al: Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol 14:52-57, 1996
10. Mirza NQ, Vlastos G, Meric F, et al: Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breastconserving therapy. Ann Surg Oncol 9:256-265, 2002
11. Bartelink H, Horiot JC, Poortmans P, et al: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345:1378-1387, 2001
12. Bartelink H, Horiot J, Poortmans P, et al: Impact of a high radiation dose on local control and survival in Breast-conserving therapy for early stage breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882. J Clin Oncol 25:3259-3265, 2007
13. Romestaing P, Lehingue Y, Carrie C, et al: Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J Clin Oncol 15:963-968, 1997
14. Early Breast Cancer Trialists Collaborative Group (EBCTCG): Effects of radiation and differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trial. Lancet 366:2087-2106, 2005
15. Jobsen JJ, van der Palen J, Ong F, et al: The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only. Int J Radiat Oncol Biol Phys 57:724-731, 2003
16. Anscher MS, Jones P, Prosnitz LR, et al: Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 218:22-28, 1993
17. Mansfield CM, Komarnicky LT, Schwartz GF, et al: Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer 75:2328-2336, 1995
18. Smitt MC, Nowels KW, Zdeblick MJ, et al: The importance of lumpectomy surgical margin status in long term results of breast conservation. Cancer 76:259-267, 1995
19. DiBiase SJ, Komarnicky LT, Schwartz GF, et al: The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 82:2212-2220, 1998
20. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al: Factors determining outcome for breastconserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys 40:851-858, 1998
21. Park CC, Mitsumori M, Nixon A, et al: Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668-1675, 2000
22. Kreike B, Hart AA, van de Velde T, et al: Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up. Int J Radiat Oncol Biol Phys 71:1014-1021, 2008
23. Goldstein NS, Kestin L, Vicini F: Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast cancer treated with breast conserving therapy. A clinicopathology study of 607 neoplasms from 583 patients. Am J Clin Pathol 120:500-527, 2003
24. Veronesi U, Salvadori B, Luini A, et al: Breast conservation is a safe method in patients with small cancer of the breast: Long-term results of three randomized trials on 1,973 patients. Eur J Cancer 31A:1574-1579, 1995
25. van Dongen JA, Bartelink H, Fentiman IS, et al: Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 28A:801-805, 1992
26. Gage I, Schnitt SJ, Nixon AJ, et al: Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 78:1921-1928, 1996
27. Zhou P, Gautam S, Recht A: Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat 101:51-57, 2007
28. Ryoo MC, Kagan AR, Wollin M, et al: Prognostic factors for recurrence and cosmesis in 393 patients after radiation therapy for early mammary carcinoma. Radiology 172:555-559, 1989
29. Spivack B, Khanna MM, Tafra L, et al: Margin status and local recurrence after breast-conserving surgery. Arch Surg 129:952-957, 1994
30. Heimann R, Powers C, Halpern HJ, et al: Breast preservation in stage I and II carcinoma of the breast: The University of Chicago experience. Cancer 78:1722-1730, 1996
31. Pezner RD, Terz J, Ben-Ezra J, et al: Now there are two effective conservation approaches for patients with stage I and II breast cancer: How pathological assessment of inked resection margins can provide valuable information for the radiation oncologist. Am J Clin Oncol 13:175-179, 1990
32. Solin LJ, Fowble BL, Schultz DJ, et al: The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 21:279-287, 1991
33. Krishnan L, Jewell WR, Krishnan EC, et al: Breast cancer with extensive intraductal component: Treatment with immediate interstitial boost irradiation. Radiology 183:273-276, 1992
34. Poortmans PM, Collette L, Horiot JC, et al: Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiother Oncol 90:80-85, 2009
35. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histologic grade in breast cancer: Experience from a large study with long-term follow-up. Histopathol 19:403-410, 1991
36. Holland R, Peterse JL, Millis RR, et al: Ductal carcinoma in situ: A proposal for a new classification. Semin Diagn Pathol 11:167-180, 1994
37. Perez C: Conservation therapy in T1-T2 breast cancer: Past, current issues and future challenges and opportunities. Cancer J :442-453, 2003
38. Jobsen JJ, Van der Palen J, Ong F, et al: Differences in outcomes for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy. Acta Oncolo 46:172-189, 2007
39. Cowen D, Houvenaeghel G, Bardou VJ, et al: Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer. Int J Radiat Oncol Biol Phys 47:305-312, 2003
40. Peterson ME, Schultz DJ, Reynolds C, et al: Outcomes in breast cancer patients relative to margin status after treatment with breast conserving surgery and radiation therapy: The University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 43:1029-1035, 1999
41. Freedman G, Fowble B, Hanlon A, et al: Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44:1005-1015, 1999
42. Pezner RD, Wagman LD, Ben-Ezra J, et al: Breast conservation therapy: Local tumor control in patients with pathological clear margins who receive 5000 cGy breast irradiation without local boost. Breast Cancer Res Treat 32:261-267, 1994
43. Vicini F, Baglan K, Kestin L, et al: The emerging role of brachytherapy in the management of patients with breast cancer. Semin Radiat Oncol 12:31-39, 2002
44. Santiago RJ, Wu L, Harris E, Fox K, et al: Fifteen-year results of breast-conserving surgery and definitive irradiation for stage 1 and II breast carcinoma: The University of Pennsylvania Experience. Int J Radiat Oncol Biol Phys 58:233-220, 2004
45. Vrieling C, Collette L, Fourquet A, et al: Can patients-treatment and pathological related characteristic explain the high local recurrence rate following breast conserving therapy in young patients? Eur J Cancer 39:932-944, 2003
46. Voogd AC, Nielsen Peterse JL, et al: Differences in risk factor for local and distant recurrence after breast conserving therapy or mastectomy for stage I or II breast cancer: Pooled result of two large European randomized trials. J Clin Oncol 19:1688-1697, 2001
47. Bollet MA, Brigitte S-Z, Mazeau V, et al: Age remains the first prognostic factor for loco-regional breast recurrence in young (< 40 years) women treated with breast barest conserving surgery first. Radiother Oncol 82:272-280, 2007
48. Antonini N, Jones H, Horiot JC, et al: Effect of age radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol 82:265-271, 2007
49. Anders CK, Hsu DS, Broadwater G, et al: Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324-3330, 2008
50. Collette S, Collette L, Budiharto T, et al: Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: A study based on the EORTC trial 22881-10882 'boost versus no boost'. Eur J Cancer 44:2587-2599, 2008